(Reuters) - Hospira Inc said U.S. health regulators issued a letter raising fresh concerns about one of the injectable-drugs maker's largest manufacturing plants in Rocky Mount, North Carolina, sending the company's shares down 4 percent.
Hospira's Rocky Mount facility has been under the FDA scanner since April 2010, when the regulator issued a warning letter stating manufacturing practices at the plant violated its defined standard practices.
The company said on Tuesday that the FDA inspected its Rocky Mount facility for three weeks and issued a letter outlining 20 concerns, three of which the agency had expressed earlier.
A number of these concerns were based on issues that are currently being resolved or have been identified by the company previously and would be addressed, Hospira said in a regulatory filing.
Source: http://news.yahoo.com/fda-flags-concerns-hospiras-rocky-mount-plant-140443889--finance.html
the talented mr ripley weather new orleans orcl the hartford illinois primary 2012 michael bay zsa zsa gabor
No comments:
Post a Comment